Precision Biosciences earnings were $7.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest DTIL earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$17.7M, up 8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DTIL reported annual earnings of $7.2M, with -111.7% growth. The next DTIL earnings date is May 12, 2025.
Precision Biosciences Earnings Reports & History FAQ
What were Precision Biosciences's earnings last quarter?
On DTIL's earnings call on Invalid Date, Precision Biosciences (NASDAQ: DTIL) reported Q4 2024 earnings per share (EPS) of -$2.82, up 30.54% year over year. Total DTIL earnings for the quarter were -$17.75 million. In the same quarter last year, Precision Biosciences's earnings per share (EPS) was -$4.06.
The next DTIL earnings call is Invalid Date. Add DTIL to your watchlist to be reminded of Precision Biosciences's next earnings date.
Is Precision Biosciences profitable or losing money?
As of the last Precision Biosciences earnings report, Precision Biosciences is currently profitable. Precision Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $7.17 million, a 111.69% decrease year over year.
What was DTIL's earnings growth in the past year?
As of Precision Biosciences's earnings date in Invalid Date, Precision Biosciences's earnings has grown year over year. DTIL earnings in the past year totalled $7.17 million.
What are Precision Biosciences's earnings expectations?
The current EPS estimate for Precision Biosciences's earnings report in Invalid Date is -$1.90.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.